Janus Henderson Group
GH icon

Janus Henderson Group’s Guardant Health GH Stock Holding History

Janus Henderson Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13M Buy
140,345
+22,844
+19% +$2.29M 0.01% 692
2025
Q4 		$12M Buy
117,501
+52,950
+82% +$4.74M 0.01% 709
2025
Q3 		$4.03M Sell
64,551
-7,334
-10% -$399K ﹤0.01% 990
2025
Q2 		$3.74M Buy
71,885
+15,207
+27% +$679K ﹤0.01% 1006
2025
Q1 		$2.45M Hold
56,678
– – ﹤0.01% 1175
2024
Q4 		$1.73M Sell
56,678
-3,900
-6% -$110K ﹤0.01% 1384
2024
Q3 		$1.39M Buy
60,578
+8,432
+16% +$239K ﹤0.01% 1493
2024
Q2 		$1.51M Sell
52,146
-603
-1% -$14K ﹤0.01% 1393
2024
Q1 		$1.09M Buy
52,749
+20
+0% +$429 ﹤0.01% 1598
2023
Q4 		$1.43M Sell
52,729
-88
-0.2% -$2.31K ﹤0.01% 1433
2023
Q3 		$1.56M Buy
52,817
+92
+0.2% +$3.23K ﹤0.01% 1314
2023
Q2 		$1.89M Buy
52,725
+14,547
+38% +$418K ﹤0.01% 1278
2023
Q1 		$895K Buy
38,178
+18,661
+96% +$533K ﹤0.01% 1700
2022
Q4 		$530K Sell
19,517
-15,319
-44% -$701K ﹤0.01% 1692
2022
Q3 		$1.87M Buy
34,836
+17,436
+100% +$895K ﹤0.01% 1335
2022
Q2 		$702K Sell
17,400
-94,548
-84% -$4.68M ﹤0.01% 1549
2022
Q1 		$7.42M Buy
111,948
+18,452
+20% +$1.26M ﹤0.01% 940
2021
Q4 		$9.35M Buy
93,496
+38,673
+71% +$4M ﹤0.01% 929
2021
Q3 		$6.85M Sell
54,823
-99,210
-64% -$11.8M ﹤0.01% 980
2021
Q2 		$19.1M Sell
154,033
-82,829
-35% -$11.1M 0.01% 792
2021
Q1 		$36.2M Buy
236,862
+14,919
+7% +$2.25M 0.02% 634
2020
Q4 		$28.6M Buy
221,943
+149,171
+205% +$17.2M 0.01% 675
2020
Q3 		$8.13M Buy
+72,772
New +$6.66M ﹤0.01% 856

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group's GH Position: Q1 2026 in Review

Janus Henderson Group increased its Guardant Health (GH) stake by 19% in Q1 2026, buying an estimated $2.29M and bringing the position to 140,345 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #692.

Janus Henderson Group first reported a position in GH in Q3 2020 and has held it in 23 quarters since. The position peaked at $36.2M in Q1 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Janus Henderson Group held 140,345 shares of Guardant Health worth $13M as of Q1 2026.
  • Janus Henderson Group bought 22,844 Guardant Health shares in Q1 2026, an estimated $2.29M.
  • Guardant Health made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #692 holding.
  • Janus Henderson Group first reported a position in Guardant Health in Q3 2020 and has held it in 23 quarters since.
  • Janus Henderson Group's Guardant Health position peaked at $36.2M in Q1 2021.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.